Sanlam (SLM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
22 Jan, 2026Executive summary
Delivered strong operational results in H1 2024, with robust profit and cash earnings growth, supported by disciplined capital allocation and successful integration of acquisitions and partnerships across South Africa, Pan-Africa, and Asia.
Diversified business model and strategic partnerships (Ubuntu-Botho, Allianz, Shriram) drove growth in Africa and India, with progress toward reaching 100 million lives by 2030.
Strategic acquisitions and integrations, including SanlamAllianz JV, Capital Legacy, and Absa/Alexforbes platforms, contributed to performance.
Board changes included appointment of Temba Mvusi as chair effective April 2024.
Financial highlights
Net result from financial services (NRFFS) up 14% to R7,056 million, with cash NRFFS per share up 20% and diluted EPS up 23% year-over-year.
Life insurance new business volumes increased 14% year-over-year; value of new business up 10%; net client cash flows up 111% to R23,972 million.
Group equity value reached R155.3 billion (7,341 cents per share); ROGEV at 9.2% and adjusted ROGEV at 10.7%, both above the 7.5% hurdle rate.
General insurance NRFFS up 16%, Santam's underwriting margin at 6.5% within target range.
Group solvency cover ratio at 166%, stable from December 2023.
Outlook and guidance
Focus for H2 2024 on maintaining profit growth, integrating Assupol, improving Retail Mass persistency, and concluding Capitec JV.
Confident in long-term outlook, with growth momentum in all markets, but global market risks and regulatory changes remain.
Implementation of 'two-pot' retirement fund legislation expected to have modest short-term outflows but benefit long-term asset accumulation.
NRFFS for 2H2024 expected to be similar to 1H2024, excluding Capitec recapture fee.
Latest events from Sanlam
- 20% normalized earnings growth, record new business, and 9% higher dividend support future growth.SLM
Q4 202512 Mar 2026 - Record new business growth and strong operations, but EPS and HEPS declined on one-offs and market factors.SLM
Q4 2025 TU5 Mar 2026 - Double-digit earnings growth, major portfolio changes, and strong cash flows marked the period.SLM
Q3 202413 Jan 2026 - Sanlam shifts asset management to Ninety One and acquires 60% of MultiChoice's insurance arm.SLM
M&A Announcement13 Jan 2026 - Double-digit earnings growth, 11% dividend increase, and strong integrations support 2025 outlook.SLM
Q4 202429 Dec 2025 - 2030 targets: >6% real earnings growth, >20% ROE, and five strategic growth vectors.SLM
CMD 202514 Dec 2025 - Double-digit normalized earnings growth, strong cash flow, and robust solvency with positive outlook.SLM
Q3 20251 Dec 2025 - Q1 2025 saw 15% net results growth, strong investment and insurance gains, and robust capital buffers.SLM
Q1 202519 Nov 2025 - Net operational earnings per share up 15%, ROGEV annualised at 18.2%, and strong cash inflows.SLM
Q2 20254 Sep 2025